Pathway Capital Management, LP Beam Therapeutics Inc. Transaction History

Pathway Capital Management, LP

  • $29.4 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$84.37 - $133.6 $9.47 Million - $15 Million
-112,197 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$64.12 - $128.71 $4.8 Million - $9.63 Million
74,798 Added 200.0%
112,197 $14.4 Million
Q1 2021

May 13, 2021
BUY
$71.28 - $120.75 $2.67 Million - $4.52 Million
37,399 New
37,399 $2.99 Million

Others Institutions Holding BEAM

# of Institutions
230
Shares Held
70.7M
Call Options Held
258K
Put Options Held
208K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.85B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Pathway Capital Management, LP Portfolio

Follow Pathway Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathway Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pathway Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email